Shilpa Medicare informs about disclosure

23 Jan 2025 Evaluate
Shilpa Medicare has informed that the company’s 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Teriflunomide.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

314.65 -9.95 (-3.07%)
19-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.35
Dr. Reddys Lab 1274.05
Cipla 1238.65
Zydus Lifesciences 876.35
Lupin 2253.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×